cliexa announces partnership with Bluenet

Bluenet and cliexa are excited to announce their new partnership, combining their strengths to develop new ways to improve patient care through technology.

This is an exciting time for the healthcare industry. With new technologies and innovative solutions being developed, we are on the cusp of a whole new era in healthcare. Bluenet and cliexa are leading the charge. They are working together to bring innovation to healthcare.

Bluenet is known for its expertise in cloud-based solutions, while cliexa is leading change in transforming patient-reported data into actionable insights for healthcare providers through the power of artificial intelligence. This partnership will allow both companies to combine their strengths and develop new ways to improve patient care. Healthcare providers can expect to see improved operational efficiencies, enhanced decision support, and better clinical outcomes from this collaboration.

Bluenet’s Managing Director, Sukru Tutak, states that “Bluenet’s mission has always been about delivering high-quality data solutions for its customers. Therefore, we were immediately impressed by cliexa’s focus on creating the best integrated patient care platform in the healthcare industry by combining quality, volume, and speed of data. Bringing these two great organizations together and letting them work toward common goals made perfect sense.”

Mehmet Kazgan, CEO and Founder at cliexa, states, “We are excited to partner with Bluenet, who has a strong background in Business Intelligence and Digital Transformation. Not only are we strengthening our resource expansion opportunity, we are also broadening our health information technology and interoperability consulting approach with Bluenet’s years of experience.”

The future of healthcare is looking very bright, and we are honored to be a part of it. We encourage you to check out what cliexa is doing; their solutions are changing the game for healthcare providers and patients alike. Together, we are ushering in a new era of healthcare innovation – one that will benefit everyone involved. Stay tuned for more updates as we work together to bring innovative solutions to healthcare!

————————–

About Cliexa:

cliexa is an end-to-end virtual health platform that provides clinicians a complete understanding of real-time patient data. cliexa removes the barriers and inaccuracies in data collection, empowering clinicians to provide personalized care. cliexa’s patented technology powered by artificial intelligence is validated with industry leaders like Mayo Clinic and the American College of Cardiology.

About Bluenet:

Founded in 2004 in Tampa, Florida, Bluenet provides its clients with services in the areas of Data & Analytics (BA), IT Talent Management, Managed IT Services, and Digital Transformation. We have distinguished ourselves in the marketplace by consistently delivering the highest-quality services that positively impact our client’s growth, competitiveness, and operational efficiency. We consider every client engagement as a strategic and long-term partnership.

 

 

Denver, CO – cliexa announces a strategic partnership with Lucem Health providing expert support and an innovative platform to help deploy and commercialize cliexa’s Opioid Use Disorder Prediction Platform in clinical settings.

 

Pain management teams must overcome significant complexity to deliver effective clinical care to opioid patients, including, managing the interplay of multiple, chronic medical conditions, behavioral health issues, and intricate medication management. This onerous process places unnecessarily high cognitive loads-on clinicians that increase the risk of burnout.

 

cliexa platform empowers pain management teams with the right data, at the right time, directly within the workflow of electronic medical records, freeing up clinic staff’s cognitive space, and enabling clinicians to make the best choice for the patient sitting in front of them.    

 

cliexa recently completed Mayo Clinic Platform-Accelerate and announced its Opioid Use Disorder Prediction Model trained with de-identified patient data provided by the Mayo Clinic Platform. cliexa also worked with technology experts from Google to ensure the highest standards of transparency and minimize bias.

 

cliexa and Lucem Health will work together and identify technical enablement and commercialization processes as well as anticipated ROI for cliexa’s predictive model in clinical settings. Lucem Health will assist cliexa by adding further insights to end users, taking cliexa’s AI model, and putting it in context for the appropriate end users.

 

“Right after our recent launch of Opioid Use Disorder Machine Learning Algorithms, Lucem Health partnership will be further verification of our platform, especially for commercialization stage and improve our delivery with industry experts. We feel extremely lucky and excited for this partnership opportunity.” Said, Mehmet Kazgan, Founder and CEO of cliexa.

 

“The Innovation Collaborative helps AI/ML and Digital Health innovators create, deploy, and commercialize clinical AI solutions that transform care,” says Sean Cassidy, CEO, Lucem Health. “Our partnership with cliexa is further testament of our continually growing partner network, and the wealth of possibilities it provides to our customers.”

“We are very pleased to see cliexa, the graduate of the first Accelerate cohort, receive support from Lucem, a Mayo Clinic Platform portfolio company,” says Eric Harnisch, vice president, Partner Programs, Mayo Clinic Platform.

 

About cliexa:

cliexa, Denver-based digital health firm, developed an end-to-end virtual health platform that provides clinicians a complete understanding of real-time patient data. cliexa removes the barriers and inaccuracies in data collection, empowering clinicians to provide personalized care. cliexa partnered with industry-leading organizations like Mayo Clinic and the American College of Cardiology to validate its patented technology powered by AI to change patients’ lives.

About Lucem Health:

Lucem Health™, launched with Mayo Clinic along with investing partners Commure (a General Catalyst company) and Rally Ventures, empowers healthcare visionaries to quickly bring AI-powered insights to the point of care. Digital health innovators develop transformative clinical solutions and advance them from the bench to the bedside to the front lines of healthcare on a single integration platform. Visionary clinical leaders deploy novel data and insights seamlessly into clinical workflows while ensuring that clinicians trust, adopt, and see value in them. For more information, visit www.lucemhealth.com.

cliexa joined Mayo Clinic Platform_Accelerate, an immersive program for health tech startups as part of its initial cohort of participating companies.

The program offers cliexa access to Mayo Clinic experts in regulatory, clinical, technology and business domains with a focus on AI model validation and clinical readiness. Technology experts from Google and Epic also will provide workshops.

"Health tech startups are critical contributors to the cycle of innovation," says John Halamka, M.D., president of Mayo Clinic Platform, a strategic initiative to improve health care through insights and knowledge derived from data. "We are excited to collaborate with these innovators to solve some of the most complex problems in medicine today."

cliexa will:

  • Work with data science experts to delineate AI model requirements.
  • Check for fairness and bias in their AI models.
  • Gain understanding of Food and Drug Administration clearance pathways.
  • Access de-identified Mayo Clinic patient data in a secure environment.
  • Conduct model validation with guidance from data science experts.
  • Plan clinical validation studies, such as clinical simulation or clinical trials.
  • Explore eligibility to partner with Mayo Clinic Platform.

"We are helping participants take a crucial step in their growth trajectory by providing startups with a disciplined focus on model validation and clinical readiness to show product value," says Eric Harnisch, Vice President of Partner Programs for Mayo Clinic Platform. "The program is integral to our Mayo Clinic Platform mission to enable new knowledge, new solutions and new technologies that improve patients' lives worldwide."

Read more at Mayo Clinic News Network Press Release here.

###

About Mayo Clinic Platform
Founded on Mayo Clinic's dedication to patient-centered care, Mayo Clinic Platform enables new knowledge, new solutions and new technologies through collaborations with health technology innovators to create a healthier world. To learn more, visit the Mayo Clinic Platform website.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.

Dr. Dhaliwal, who recently joined cliexa’s executive management team will be leading strategic growth at cliexa. Dr. Dhaliwal, is a physician entrepreneur, has been serving as CEO of Momentum Healthcare Staffing, board member of two VC funds and other healthcare startups. Dr. Dhaliwal also served as the Associate Medical Director of Prognos Health. With his innovative approach and passion in healthcare technology, Dr. Dhaliwal as a practicing physician is highly optimistic about putting a dent on today’s healthcare challenges by partnering with cliexa.

 

“As a physician and executive, I am excited to be a member of cliexa family. cliexa is truly an innovative solution to not only increase clinical efficiency but also to improve reimbursement within institutions. It will be a great journey to work with cliexa staff and advisors to grow this one stop shop solution, providing a complete platform for patient journey.” said Dr. Dhaliwal.

 

cliexa since the inception in late 2016, expanded its solutions offering, intelligent patient triage and onboarding, integrated EMR solutions, quality and compliance add-ons and remote patient monitoring. In June 2021, cliexa and American College of Cardiology announced the launch of cliexa-PULSE, device and EMR agnostic patient engagement and remote patient monitoring platform that leverages patient-centered data with multiple co-morbidities. cliexa uses patented clinical data processing algorithms (USPTO Patent# 10628555: evidence-based data collection, processing and indexing algorithms) and now leveraging American College of Cardiology’s proprietary risk algorithms for cardiovascular conditions.

 

“With Dr. Dhaliwal’s leadership in growth strategy, combined with Dr. Kowalcyzk’s clinical and business guidance, cliexa will be taking a big step in onboarding new customers and expanding its footprint with current health system contracts” said Mehmet Kazgan, Founder and CEO of cliexa.

 

 

 

 

University of Colorado College of Nursing Partners with cliexa to Launch a Mobile Application with Evidence-based Infographics

HIV disproportionately affects Latinos who experience higher prevalence, faster disease progression, more HIV-related deaths, and a marked delay in diagnosis and treatment than their white counterparts. This is a concern in geographic regions across the United States (US) as Latinos comprise the largest minority group in the US. Similar HIV-related health disparities exist in developing countries, such as the Dominican Republic (DR), where those with low socioeconomic status experience higher disease burdens and worse outcomes than those with higher socioeconomic status. These health disparities are exacerbated when affected individuals have low health literacy and are unable to understand the information needed for self-management, as inability to self-manage leads to less use of healthcare services and worse understanding of illness, health behaviors, and health outcomes.  Therefore, to improve health outcomes and reduce health disparities among Latino persons living with HIV (PLWH), clinicians must provide the health information needed for effective self-management to diverse Latino PLWH in a meaningful way.

In response to these concerns, Dr. Samantha Stonbraker, Assistant Professor at the University of Colorado College of Nursing, rigorously and iteratively developed the Info Viz for Health intervention to assist clinicians to provide this health information to PLWH through several NIH-funded studies. She first identified a need for this intervention (T32 NR013454).1-3 Then, she worked with an expert visualization team at Columbia University in New York and with health care providers and PLWH at a clinic in the Dominican Republic to develop a set of culturally relevant and evidence-based infographics to assist clinical communication (T32 NR007969).4, 5 She has since assessed the feasibility of using the Info Viz for Health intervention to improve clinical communication with, and outcomes of, PLWH in the DR.6, 7 She also adapted infographics to the cultural and clinical context of Latino PLWH living in New York (NY), who are mainly of Dominican origin/descent and also assessed their feasibility and acceptability at a clinic specializing in HIV care in Northern Manhattan (K99 NR017829).

Two critical next steps in this work were:

  • To adapt Info Viz for Health for relevance to heterogeneous Latino populations across the US by adapting them to Latinos of Mexican origin/descent as these individuals form the largest Latino group in the US and their inclusion is necessary to enhance generalizability and enable future scalability of the intervention. To do this, Dr. Stonbraker conducted a series of in-depth interviews with PLWH attending a clinic that specializes in HIV care in Denver, CO, and adapted the infographics accordingly.
  • To integrate the Info Viz for Health infographics into a mobile platform to enable ease of use and scalability. Dr. Stonbraker teamed up with cliexa, an innovative company that develops and creates digital health solutions. Together, they incorporated the Info Viz for Health into a mobile app that is now accessible on the App Stores both in Apple and Google in English and Spanish languages.

Currently, Dr. Stonbraker is conducting a multi-site randomized controlled trial (RCT) to evaluate the efficacy of using the Info Viz for Health app to improve clinical communication and treatment outcomes of Latino PLWH at clinical sites in CO and the DR. Seven providers at the two different clinical sites are using the Info Viz for Health app as a communication aid while they provide information to study participants.

The research aims of this project are to:

Aim 1 Assess the efficacy of the intervention as compared to standard care in improving treatment outcomes (CD4 count, viral load, self-efficacy to manage HIV, among others) of PLWH and determine how resultant effects vary over time (baseline to 9-months) and between sites.

Aim 2 Evaluate the feasibility, acceptability, and usability of the app among interdisciplinary and multi-cultural providers using the app.

Aim 3 Identify implementation factors of integrating the mobile app into electronic health records (HER) through in-depth interviews and leverage findings to ensure the app effectively interfaces with EHRs in the US and DR.

Next steps:

  • Health care providers at all sites where infographics have been used have requested additional infographics be incorporated into the app so that they can address additional topics with their patients. Dr. Stonbraker will conduct a needs assessment to identify the pertinent topics to include next and will create rigorously designed and culturally appropriate infographics in response to identified needs.
  • The Info Viz for Health app is provider-facing and would benefit from integration with EHRs. Therefore, the next step in app development is to integrate it with Fast Healthcare Interoperability Resources (FHIR)®, which is the standard for connecting mobile apps and electronic health records (EHR). This permits scalability, as the resultant app enables clinicians to easily access evidence-based infographics from diverse settings globally.

The final product will be an app that interfaces with EHRs in resourced and under-resourced areas globally, has been rigorously tested amongst diverse Latino PLWH in distinct geographic settings in multiple languages, and includes evidence-based infographics to facilitate the clinical communication that helps patients improve their self-management and obtain better health.

References

 

  1. Stonbraker S, Smaldone A, Luft H, et al. Associations between health literacy, HIV-related knowledge, and information behavior among persons living with HIV in the Dominican Republic. Public Health Nurs. 2017;35(3):166-175. doi:10.1111/phn.12382
  2. Stonbraker S, Befus M, Lerebours Nadal L, Halpern M, Larson E. Factors associated with health information seeking, processing, and use among HIV positive adults in the Dominican Republic. AIDS Behav. 2016;21(6):1588–1600. doi:10.1007/s10461-016-1569-5
  3. Stonbraker S, Larson E. Health-information needs of HIV-positive adults in Latin America and the Caribbean: an integrative review of the literature. AIDS Care. 2016;28(10):1223-1229. doi:10.1080/09540121.2016.1173645
  4. Stonbraker S, Halpern M, Bakken S, Schnall R. Special Section on Visual Analytics in Healthcare: Developing infographics to facilitate HIV-related patient-provider communication in a limited-resource setting. Appl Clin Inform. 2019;10:597-609. doi:10.1055/s-0039-1694001
  5. Stonbraker S, Richards SD, Halpern M, Bakken S, Schnall R. Priority topics for health education to support HIV self-management in limited-resource settings. J Nurs Scholarsh. 2019;51(2):168-177. doi:10.1111/jnu.12448
  6. Stonbraker S, Flynn G, George M, et al. Feasibility and acceptability of using information visualizations to improve HIV-related communication in a limited-resource setting: A short report. AIDS Care. In Press;doi:10.1080/09540121.2021.1883517
  7. Stonbraker S, Liu J, Sanabria G, et al. Clinician Use of HIV-Related Infographics During Clinic Visits in the Dominican Republic is Associated with Lower Viral Load and Other Improvements in Health Outcomes. AIDS Behav. In Press:1-13. doi:10.1007/s10461-021-03331-8